Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Actos
Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Bloomberg
Actos
bladder cancer
diabetes
Takeda
Jury hits Takeda with $6.5M judgment in first Actos liability case
Jury hits Takeda with $6.5M judgment in first Actos liability case
Fierce Pharma
Actos
bladder cancer
diabetes
Takeda
Takeda Put Actos Sales Ahead of User Safety, Witness Says
Takeda Put Actos Sales Ahead of User Safety, Witness Says
Bloomberg
Actos
diabetes
Takeda
type 2 diabetes
Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Bloomberg
Actos
diabetes
Takeda
Takeda Worried About Actos’s Cancer Link, Filing Shows
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Actos
cancer
diabetes
Takeda
type 2 diabetes
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Actos
diabetes
FDA
Takeda
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Actos
alogliptin
diabetes
Furiex Pharmaceuticals
Takeda
type 2 diabetes
Watson Receives FDA Approval for Generic Actos®
Watson Receives FDA Approval for Generic Actos®
Equities.com
Actos
generics
Watson Pharmaceuticals
Watson Pharma Sues FDA
Watson Pharma Sues FDA
Zacks
Actos
generics
Watson Pharmaceuticals
Takeda's Actos era ends with generic launches
Takeda's Actos era ends with generic launches
Fierce Pharma
Actos
diabetes
generics
Takeda
type 2 diabetes
1
2
3
4
5
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT